| Financial Year |
March 31 2023 |
| Monetary Funds |
362,927,315.61 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
170,643,274.60 |
| Accounts Receivable |
675,729,328.40 |
| Advances to Suppliers |
31,975,507.46 |
| Other Receivables |
21,774,587.51 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
508,517,891.24 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,485,418.28 |
| Total Current Assets |
1,958,259,197.83 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
35,484,602.21 |
| Investment Properties |
-- |
| Fixed Assetes |
243,711,599.41 |
| Under-construction Projects |
94,472,244.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
67,186,161.02 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,540,827.74 |
| Deferred Income Tax Assets |
21,561,387.55 |
| Other Non-Current Assets |
5,589,467.82 |
| Sub-Total of Non-Current Assets |
619,014,971.15 |
| Total Assets |
2,577,274,168.98 |
| Short-Term Loans |
84,036,993.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
270,495,569.90 |
| Accounts Payable |
482,075,994.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
37,469,693.86 |
| Taxes Payable |
11,956,756.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,364,291.34 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,347,253.20 |
| Other Current Liabilities |
208,427,379.62 |
| Sub-Total of Current Liabilities |
1,197,892,236.77 |
| Long-term Loans |
67,274,285.40 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
1,455,530.99 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
114,268,164.60 |
| Total Liabilities |
1,312,160,401.37 |
| Paid-In Capital(Or Share Stock) |
504,702,276.00 |
| Capital Surplus |
593,046,511.50 |
| Surplus Reserve |
38,469,401.67 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
96,015,569.24 |
| Minority Stockholder's Interest |
24,389,572.25 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,240,724,195.36 |
| Owner's Equity（Stockholder's Equity） |
1,265,113,767.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,577,274,168.98 |
